Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02192008Completed
Randomised, open-label trial (3 arms), sponsored by University of Oxford. Primary endpoint: Attack rate after challenge with S. Typhi or S. Paratyphi A at 12 months. Started Dec 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02192008.